CClinicalTrials.gg
CompletedNCT02937987Updated Jan 31, 2019

Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients

An observational study in Type 2 Diabetes Mellitus in Obese, sponsored by Chinese University of Hong Kong. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-01-31.

Sponsored by Chinese University of Hong Kong · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
211
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The objective of this study is to describe and examine the dietary intake, eating behavior and physical activity level of a cohort of Hong Kong Chinese with T2DM and their association with weight and glycemic control at baseline and 1 year follow-up. The investigators hypothesize that Hong Kong Chinese T2DM patients with unhealthy dietary intake and pattern and low physical activity level are associated with poorer glycemic and weight control, and there will be no improvement with weight and glycemic control under usual care after 1 year.

02

Conditions studied

  • Type 2 Diabetes Mellitus in Obese
03

In context

Diabetes Mellitus, Type 2

9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.

This study's planned enrollment of 211 is below the median of 300 across 1,588 observational studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Hong Kong Chinese T2DM patients referred to the Prince of Wales Hospital (PWH) diabetes centre

Inclusion criteria

  1. Male or female of Chinese ethnicity
  2. Diagnosis of T2DM
  3. Able to read Chinese and give informed written consents

Exclusion criteria

Exclusion Criteria:

  1. Type 1 diabetes mellitus
  2. End-stage renal failure requiring dialysis or chronic kidney disease (CKD) stage 4 or above
  3. Malignancy diagnosed within 3 years
  4. Pregnancy or lactation
  5. Any medical illness or condition as judged by the investigators as ineligible to participate the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
211 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group 1

    non-obese type 2 DM

  • Group 2

    obese type 2 DM

06

What researchers measure

Primary outcomes

  1. Change of HbA1c

    Time frame: 1 year

  2. Change of Weight

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 31, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02937987
Lead sponsor
Chinese University of Hong Kong
Responsible party
Lorena Tsui Fun Cheung (PhD student in medical science, Chinese University of Hong Kong) — Principal investigator
First posted
Oct 19, 2016
Start date
Apr 2016
Primary completion
Mar 2018
Completion
Mar 2018
Last update
Jan 31, 2019
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion